Coming Soon: GMP-Grade Recombinant Monoclonal Antibody Conjugates for Cell Therapy Manufacturing & QC
Incorporate robust, flexible CAR-T Cell Enrichment and Detection into Your Manufacturing and QC Workflows
CST revolutionized pre-clinical CAR cell characterization with universal recombinant monoclonal antibodies specific to the ubiquitous Whitlow/218 and G4S linker sequences of scFv-based CARs. This innovation enabled scientists to use a single reagent for a variety of assays without the time or cost of developing anti-idiotype antibodies for every CAR construct.
These trusted antibody conjugates, manufactured to be GMP-grade, are intended to simplify enrichment of G4S linker CAR+ cells and increase productivity for in-process QC and lot release assays. When pre-clinical development teams use the same reagents, handoffs to clinical production can be that much easier.
| CAR+ Cell Enrichment in Manufacturing | |
G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) (GMP-Grade)
| |
| CAR+ Cell Detection for Analytical QC | |
G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) (GMP-Grade)
| |
| Seamless Transfer from Pre-Clinical to Clinical | |
| |
| Reagent Security and Supply Continuity | |
| |
For Research and Evaluation Use Only. Commercial GMP-Grade Reagent Availability is Anticipated in Mid-2026.